Literature DB >> 7746618

Repair of retinal detachment associated with congenital excavated defects of the optic disc.

G C Brown1, M M Brown.   

Abstract

Excavated defects of the optic disc have been associated with retinal detachment in the macula and beyond. Included among these defects are congenital pits of the optic disc, optic nerve colobomas, and the morning glory syndrome. We report eight consecutive patients with congenital, excavated defects of the optic disc and associated retinal detachment managed with pars plana vitrectomy, laser photocoagulation, and intravitreal gas injection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746618

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  5 in total

1.  Optical coherence tomography in optic pit maculopathy managed with vitrectomy-laser-gas.

Authors:  José García-Arumí; Borja Corcóstegui Guraya; Ana Boixadera Espax; Vicente Martínez Castillo; Laura Sararols Ramsay; R Max Motta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-04-07       Impact factor: 3.117

2.  Vitreoretinal surgery for optic pit associated serous macular detachment: a discussion of two cases.

Authors:  Sophie J Bakri; Paul M Beer
Journal:  Int Ophthalmol       Date:  2004-05       Impact factor: 2.031

3.  Rhegmatogenous retinal detachment in morning glory syndrome pathogenesis and treatment.

Authors:  C L Ho; L C Wei
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

4.  Intraoperative optical coherence tomography assisted analysis of pars Plana vitrectomy for retinal detachment in morning glory syndrome: a case report.

Authors:  Lyubomyr M Lytvynchuk; Carl G Glittenberg; Siamak Ansari-Shahrezaei; Susanne Binder
Journal:  BMC Ophthalmol       Date:  2017-08-01       Impact factor: 2.209

5.  Surgical outcomes in patients with optic disc pit maculopathy: does peeling the ILM lead to better outcomes?

Authors:  Helena Wagner; Amelie Pielen; Hansjürgen Agostini; Daniel Böhringer; Wolf Alexander Lagrèze; Julia Biermann
Journal:  Int Ophthalmol       Date:  2020-08-01       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.